The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries ...

Healthcare stocks rallied in 2025, breaking a two-year slump as investors chased steadier rates, better valuations, and ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...

Detailed price information for Tango Therapeutics Inc (TNGX-Q) from The Globe and Mail including charting and trades.

The drug and biotech sector witnessed a see-saw performance in 2025. After a weak show for most of the year, the sector picked up in the past couple of months. This can be attributed to improved ...

After a weak first half, the drug and biotech sector regained momentum in the latter part of 2025, setting the stage for a strong year for select stocks. Improved policy clarity following most large ...

We recently compiled a list of the 15 High Growth Mid-Cap Stocks to Buy. PTC Therapeutics, Inc. is among the best high growth ...

Other useful metrics include insider buying and levels of short activity, which offer stronger predictive signals than ...